Evidence map›Paper›PMID 42467876›Full record

ArticleJCO clinical cancer informatics

Influence of Fractionation and Beam Sequencing on Absorbed Dose to Circulating Lymphocytes During Ultra-High Dose Rate and Conventional Radiotherapy: An In Silico Study.

François de Kermenguy, Camilla Satragno, Mohammed El-Aichi, Ibrahima Diallo, Cristina Veres, Fereshteh Talebi, Cathyanne Schott, Eric Deutsch, Charlotte Robert

Abstract read
In one paragraph

Article in JCO clinical cancer informatics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

François de KermenguyInserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0000-0003-3293-6471
Camilla SatragnoInserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0000-0003-2865-5845
Mohammed El-AichiInserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0009-0005-3642-5814
Ibrahima DialloInserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0000-0002-8272-8817
Cristina VeresInserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0000-0002-6583-0334
Fereshteh TalebiDépartement de radiothérapie, Gustave Roussy, Villejuif, France.
Cathyanne SchottInserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0009-0009-8582-3244
Eric DeutschInserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Charlotte RobertInserm U1030 Radiothérapie Moléculaire et Innovation Thérapeutique, Gustave Roussy, Université Paris-Saclay, Villejuif, France.ORCID 0000-0001-8838-1343

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSeveral in silico models concluded that ultra-high dose rate (UHDR) radiotherapy could spare large quantities of circulating lymphocytes. However, preclinical studies failed to show a reduction in radiation-induced lymphopenia after UHDR irradiation compared with conventional dose rates (CONV). This study aims to investigate the influence of fractionation and beam sequencing on absorbed dose to circulating lymphocytes during CONV and UHDR irradiations. MATERIALS AND

methodsThe LymphoDose framework was applied to a cohort of 162 patients treated for brain tumors with 3D conformal radiotherapy. Four scenarios of UHDR treatment were compared: (S1) one fraction with all beams delivered simultaneously, (S2) one fraction with sequentially delivered beams, (S3) three fractions with all beams delivered simultaneously, and (S4) three fractions with sequentially delivered beams.

resultsUHDR fractionation and the beam delivery scheme had a significant impact on irradiated blood volume (1.3% ± 0.1% for S1

conclusionThe doses delivered to lymphoid organs account for a substantial portion of the total dose received by the lymphocyte pool, showing only a limited difference between UHDR and CONV in terms of lymphocyte exposure. The fractionation strategy of UHDR irradiation beams could play an important role in successfully translating UHDR treatments into clinical practice.

Indexed as

Brain NeoplasmsDose Fractionation, RadiationLymphocytesRadiotherapy, ConformalComputer SimulationHumansRadiotherapy DosageRadiotherapy Planning, Computer-Assisted

Identifiers

PMID42467876
PMCPMC13399734

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.